These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
588 related items for PubMed ID: 15988855
1. International Conference on Harmonisation; guidance on Q5E Comparability of Biotechnological/Biological Products Subject to Changes in Their Manufacturing Process; availability. Notice. Food and Drug Administration, HHS. Fed Regist; 2005 Jun 30; 70(125):37861-2. PubMed ID: 15988855 [Abstract] [Full Text] [Related]
2. International Conference on Harmonisation; guidance on good manufacturing practice for active pharmaceutical ingredients; availability. Notice. Food and Drug Administration, HHS. Fed Regist; 2001 Sep 25; 66(186):49028-9. PubMed ID: 12358036 [Abstract] [Full Text] [Related]
3. International Conference on Harmonisation; guidance on specifications: test procedures and acceptance criteria for biotechnological/biological products. Notice. Food and Drug Administration, HHS. Fed Regist; 1999 Aug 18; 64(159):44928-35. PubMed ID: 12356094 [Abstract] [Full Text] [Related]
4. International Conference on Harmonisation; guidance on quality of biotechnological/biological products: derivation and characterization of cell substrates used for production of biotechnological/biological products; availability. Notice. Food and Drug Administration, HHS. Fed Regist; 1998 Sep 21; 63(182):50244-9. PubMed ID: 12269373 [Abstract] [Full Text] [Related]
5. International Conference on Harmonisation; guidance on Addendum to E2C Clinical Safety Data Management: Periodic Safety Update Reports for Marketed Drugs; availability. Notice. Food and Drug Administration, HHS. Fed Regist; 2004 Feb 05; 69(24):5551-2. PubMed ID: 14968802 [Abstract] [Full Text] [Related]
6. International Conference on Harmonisation; guidance on Q9 Quality Risk Management; availability. Notice. Food and Drug Administration, HHS. Fed Regist; 2006 Jun 02; 71(106):32105-6. PubMed ID: 16795933 [Abstract] [Full Text] [Related]
7. International Conference on Harmonisation; revised guidance on Q3B(R) Impurities in New Drug Products; Availability. Notice. Food and Drug Administration, HHS. Fed Regist; 2003 Nov 14; 68(220):64628-9. PubMed ID: 14619944 [Abstract] [Full Text] [Related]
8. International Conference on Harmonisation; evaluation of stability data; availability. Notice. Food and Drug Administration, HHS. Fed Regist; 2004 Jun 08; 69(110):32010-1. PubMed ID: 15185712 [Abstract] [Full Text] [Related]
9. International Conference on Harmonisation: guidance on Q1D bracketing and matrixing designs for stability testing of new drug substances and products; availability. Notice. Food and Drug Administration, HHS. Fed Regist; 2003 Jan 16; 68(11):2339-40. PubMed ID: 12532979 [Abstract] [Full Text] [Related]
10. International Conference on Harmonisation; guidance on S7A safety pharmacology studies for human pharmaceuticals; availability. Notice. Food and Drug Administration, HHS. Fed Regist; 2001 Jul 13; 66(135):36791-2. PubMed ID: 12356097 [Abstract] [Full Text] [Related]
11. International Conference on Harmonisation; Guidance on S8 Immunotoxicity Studies for Human Pharmaceuticals; availability. Notice. Food and Drug Administration, HHS. Fed Regist; 2006 Apr 13; 71(71):19193-4. PubMed ID: 16612859 [Abstract] [Full Text] [Related]
12. International Conference on Harmonisation; revised guidance on Q3A impurities in new drug substances; availability. Notice. Food and Drug Administration, HHS. Fed Regist; 2003 Feb 11; 68(28):6924-5. PubMed ID: 12583358 [Abstract] [Full Text] [Related]
13. International Conference on Harmonisation; Guidance on Q8 Pharmaceutical Development; availability. Notice. Food and Drug Administration, HHS. Fed Regist; 2006 May 22; 71(98):29344-5. PubMed ID: 16749216 [Abstract] [Full Text] [Related]
14. International Conference on Harmonisation; draft guidance on E2F Development Safety Update Report; availability. Notice. Food and Drug Administration, HHS. Fed Regist; 2008 Aug 05; 73(151):45462-3. PubMed ID: 18949880 [Abstract] [Full Text] [Related]
15. International Conference on Harmonisation; Guidance on Q11 Development and Manufacture of Drug Substances; availability. Notice. Food and Drug Administration, HHS. Fed Regist; 2012 Nov 20; 77(224):69634-5. PubMed ID: 23227566 [Abstract] [Full Text] [Related]
16. International Conference on Harmonisation; guidance on Q10 Pharmaceutical Quality System; availability. Notice. Food and Drug Administration, HHS. Fed Regist; 2009 Apr 08; 74(66):15990-1. PubMed ID: 19507321 [Abstract] [Full Text] [Related]
17. International Conference on Harmonisation; guidance on Q1A stability testing of new drug substances and products; availability. Notice. Food and Drug Administration, HHS. Fed Regist; 2001 Nov 07; 66(216):56332-3. PubMed ID: 12358038 [Abstract] [Full Text] [Related]
18. International Conference on Harmonisation; guidance on Q8(R1) Pharmaceutical Development; addition of annex; availability. Notice. Food and Drug Administration, HHS. Fed Regist; 2009 Jun 09; 74(109):27325-6. PubMed ID: 19588572 [Abstract] [Full Text] [Related]
19. International Conference on Harmonisation; guidance on electronic common technical document specification; availability. Notice. Food and Drug Administration, HHS. Fed Regist; 2003 Apr 02; 68(63):16060-1. PubMed ID: 12674113 [Abstract] [Full Text] [Related]
20. International Conference on Harmonisation; guidance on E11 clinical investigation of medicinal products in the pediatric population; availability. Notice. Food and Drug Administration, HHS. Fed Regist; 2000 Dec 15; 65(242):78493-4. PubMed ID: 12362934 [Abstract] [Full Text] [Related] Page: [Next] [New Search]